Skip to main content
Log in

The Influence of Probiotics in Reducing Cisplatin-Induced Toxicity in Zebrafish (Danio rerio)

  • Short Communication
  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

In this work, the effects of probiotic supplementation on cisplatin toxicity in zebrafish (Danio rerio) were examined. For this study, adult female zebrafish were given cisplatin (G2), the probiotic, Bacillus megaterium (G3), and cisplatin+B. megaterium (G4) for 30 days, in addition to the control (G1). In order to investigate changes in antioxidative enzymes, ROS production, and histological changes after treatment, the intestines and ovaries were excised. The levels of lipid peroxidation, glutathione peroxidase, glutathione reductase, catalase, and superoxide dismutase were found to be significantly higher in the cisplatin group than in the control group in both the intestine and the ovaries. Administration of the probiotic and cisplatin effectively reversed this damage. Histopathological analyses showed that the cisplatin group had much more damage than the control group and that probiotic+cisplatin treatment significantly cured these damages. It opens the door to probiotics being combined with cancer-related drugs, which may be a more efficient approach for minimizing side effects. The underlying molecular mechanisms of probiotics must be further investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Górska A, Przystupski D, Niemczura MJ, Kulbacka J (2019) Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol 76:939–949

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Karasawa T, Steyger PS (2015) An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 237(3):219–227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Johnstone TC, Suntharalingam K, Lippard SJ (2016) The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chem Rev 116:3436–3486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ozen M, Dinleyici EC (2015) The history of probiotics: the untold story. Benef Microbes 6:159–165

    Article  CAS  PubMed  Google Scholar 

  6. Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, Doetsch PW (2013) Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE 8(11):e81162

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kandati K, Belagal P, Nannepaga JS, Buddolla V (2022) Role of probiotics in the management of cervical cancer: an update. Clin Nutr ESPEN. https://doi.org/10.1016/j.clnesp.2022.02.017

    Article  PubMed  Google Scholar 

  8. Sun B, Liu M, Tang L, Hu C, Huang Z, Zhou X, Chen L (2021) Probiotic supplementation mitigates the developmental toxicity of perfluorobutanesulfonate in zebrafish larvae. Sci Total Environ 799:149458

    Article  CAS  PubMed  Google Scholar 

  9. Waziri A, Bharti C, Aslam M, Jamil P, Mirza M, Javed MN, Alam MS (2022) Probiotics for the chemoprotective role against the toxic effect of cancer chemotherapy. Anti-Cancer Agents Med Chem 22(4):654–667

    Article  CAS  Google Scholar 

  10. Azizpour Maghvan M, Jafari PJ, Anushiravani AA (2022) Investigating the influence of probiotic bacteria on anemia and white blood cells count in cancer patients undergoing chemotherapy and radiation therapy. Multidiscip Cancer Investig 6(3):1–6

    Article  Google Scholar 

  11. Jakubauskas M, Jakubauskiene L, Leber B, Horvath A, Strupas K, Stiegler P, Schemmer P (2022) Probiotic supplementation suppresses tumor growth in an experimental colorectal cancer liver metastasis model. Int J Mol Sci 23(14):7674

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Alam Z, Shang X, Effat K, Kanwal F, He X, Li Y, Zhang Y (2022) The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer. J Food Biochem. https://doi.org/10.1111/jfbc.14302

    Article  PubMed  Google Scholar 

  13. Ruch RJ, Crist KA, Klaunig JE (1989) Effects of culture duration on hydrogen peroxide-induced hepatocyte toxicity. Toxicol Appl Pharmacol 100(3):451–464

    Article  CAS  PubMed  Google Scholar 

  14. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–358

    Article  CAS  PubMed  Google Scholar 

  15. Carlberg IN, Mannervik BE (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250(14):5475–5480

    Article  CAS  PubMed  Google Scholar 

  16. Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophysics.

  17. Aebi H (1984) Catalase in vitro. Meth Enzymol 105:121–126

    Article  CAS  Google Scholar 

  18. Jia M, Wang Y, Wang D, Teng M, Yan J, Yan S, Meng Z, Li R, Zhou Z, Zhu W (2019) The effects of hexaconazole and epoxiconazole enantiomers on metabolic profile following exposure to zebrafish (Danio rerio) as well as the histopathological changes. Chemosphere 226:520–533

    Article  CAS  PubMed  Google Scholar 

  19. Yan F, Polk DB (2011) Probiotics and immune health. Curr Opin Gastroenterol 27(6):496

    Article  PubMed  PubMed Central  Google Scholar 

  20. Molska M, Reguła J (2019) Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients 11(10):2453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Dr. Subramanyam Dasari, Indiana University and Dr. Mallikarjuna Nimgampalle, IISER Tirupati, India for their help in revising this manuscript. We are also thankful to Dr. Buddolla’s Institute of Life Sciences for their technical support.

Author information

Authors and Affiliations

Authors

Contributions

KK: Methodology, Data curation, Formal analysis, Writing – original draft. ASR: Data curation, Investigation, Formal analysis. JSN: Data curation, Investigation, Formal analysis, Supervision. BV: Conceptualization, Investigation, Supervision, Validation, Funding acquisition, Project administration, Writing—review & editing.

Corresponding authors

Correspondence to John Sushma Nannepaga or Buddolla Viswanath.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Ethical Approval

All experiments have been conducted as per the guidelines of the Institutional Animal Ethics Committee, Dr. Buddolla’s Institute of Life Sciences, Tirupati, India (Registration No. 2172/PO/Re/S/2022/CPCSEA dated 9th June 2022

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 84 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kandati, K., Reddy, A.S., Nannepaga, J.S. et al. The Influence of Probiotics in Reducing Cisplatin-Induced Toxicity in Zebrafish (Danio rerio). Curr Microbiol 80, 109 (2023). https://doi.org/10.1007/s00284-023-03203-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00284-023-03203-5

Navigation